evidencegaps
Primary study · included by 1 review

Liposomal Bupivacaine Use in Third Molar Impaction Surgery: INNOVATE Study.

Lieblich 2017 (INNOVATE) · Lieblich Stuart E, Danesi Hassan · Anesthesia progress · 2017

Included by

Efficacy of Liposomal Bupivacaine in Third Molar Extraction: A Systematic Review and Meta-Analysis.
Non-Cochrane · intervention · 2026 · cited as Lieblich 2017 (INNOVATE) · Table 2; Figures 3-4; reference list
Outcome this study informsPooled effectEvidenceCertainty
Total opioid consumption (morphine milligram equivalents)
Liposomal bupivacaine infiltration vs Standard bupivacaine or placebo · 48 hours
MD -1.20 [-1.79, -0.61]2 studies · 174 participantsGRADE not reported
Cumulative postoperative pain score (NRS)
Liposomal bupivacaine infiltration vs Standard bupivacaine or placebo · 0-48 hours
SMD -1.06 [-2.52, 0.39]2 studies · 294 participantsGRADE not reported

Also linked to PM42005128-P1-O4, which does not match a current question in this review.

1 including review in total.